Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics
←Back to story

UK approves J&J's oral psoriasis pill | Reuters

ReutersView source article

Part of story

UK approves Johnson & Johnson's oral psoriasis pill for moderate-to-severe plaque psoriasis

Britain's medicines regulator approved Johnson & Johnson's daily pill for adults and teenagers with moderate-to-severe plaque psoriasis, a skin condition causing red, scaly and often itchy patches.

Oct 23, 2026·2 sourcesDrug Policy, Pricing & ApprovalAutoimmune disease treatmentsPharmaceutical IndustryPharmaceutical drugsDrug approval processAutoimmune disease
UK approves Johnson & Johnson's oral psoriasis pill for moderate-to-severe plaque psoriasis
00

Other sources for this story

Medscape

UK Approves J&J's Oral Psoriasis Pill